Guest viewing limit reached
  • You have reached the maximum number of guest views allowed
  • Please register below to remove this limitation

Letro and Drinking

super F Bomb

New member
I searched everywhere and have not found anything on it.

I am wondering if it would be ok to have a few beers while on letro?
 

More than 100,000 U.S. deaths are caused by excessive alcohol consumption each year.

you make the decision


haha.. but seriously, drinking does elevate estrogen, so it'll only weaken ur letro use. no worse effects on the liver to my knowledge
 
Well been on letro now for 20 days and drinking hasn't effected me yet so thats good, but i guess nolvadex is the toxic one so drink on it.
 
You should NOT be drinking while on cycle or PCT at all. Just because you don't see any sides doesn't mean they aren't there. Drinking raises your estrogen levels and will kill your plasma levels. You will only be hindering your gains. It be a smart idea to stay away from the booze while on cycle & PCT.
 
You should NOT be drinking while on cycle or PCT at all. Just because you don't see any sides doesn't mean they aren't there. Drinking raises your estrogen levels and will kill your plasma levels. You will only be hindering your gains. It be a smart idea to stay away from the booze while on cycle & PCT.

thanks, and i'm gonna cut back majorly this new year. fyi, no roids or ph's here:redeemerwhore:
 
You didn't search everywhere.:yawn2:

Invalid Link Removed

The manufacturer's monogram is usually a good place to start. In terms of drug interactions, what applies to the pill usually applies to the liquid, so it doesn't matter which you are using. Navigate to the drug interactions section and clinical pharmacology-special populations section. If a drug or hepatic-type interaction isn't listed, then the interaction likely doesn't exist (according to the manufacturer at least).

Invalid Link Removed

As for the safety of Nolva, AI's are definitely safer, though they serve different purposes relative to anabolics (duh). Note the FDA Black Box Warning on the first page of the Nolvadex monogram before you cry "safe". The dreaded-by-manufacturers, Black Box Warning is the strongest warning the FDA can put on an RX product short of taking it off the market. The newer SERMs are getting safer (toremifene, etc), and while a cycle or two of Nolva doesn't necessarily mean that you are going to develop secondary malignancies (cancer/tumors), there are various risks inherent in its use, more so than with letro, including some rare, fatal ones. Basically, I wouldn't take the use of SERMs any more lightly than I would the use of 17aa steroids. I didn't say I don't use them:biglaugh:.

Invalid Link Removed

No black box warning for toremifene. But if you keep reading, it seems to be worse than Nolva in terms of cataract formation, elevated liver tests, etc. I guess it is safer overall, but still lots of room to improve in the land of SERMs. Also torem is from the nolva family of SERMs (older generation). Newer ones are out that should be safer, but they haven't been studied well and have limited availability in North America at least.

I agree that drinking on or post cycle makes no since. Alcohol hurts your metabolism (even a little bit does), and chronic use can actually screw your hormones up so badly (test down, est up) that gyno secondary to alcoholism is not uncommon.

I def wouldn't drink with Nolva (or Torem) b/c Nolva (and even torem) is somewhat toxic to the liver in and of itself; not 17aa toxic, but some reports of liver cancer and lesser signs of toxicity.

There is no direct interaction with letrozole. However, plasma levels of letro seem to increase in some cases of hepatic dysfunction/insufficiency (see the link above and find the specific sections).

If you are coming off a cycle of anything 17aa, then your bilirubin and/or AST/ALT are most likely elevated and outside the normal range, even if you took proper OCT.

I didn't read the whole thread, so I don't know what of this applies to you. You kind of have to make your own applications based on the less explicit mfg findings.
 
Back
Top